Biovitrum Sharpens Strategic Focus, Increases Resources to Later Development Phases and Restructures Early Discovery
06 oct. 2005 09h17 HE
|
Biovitrum
STOCKHOLM, Sweden, Oct. 06, 2005 (PRIMEZONE) -- Biovitrum's project portfolio has developed very positively during 2005. It has today several projects in or near clinical phase within diabetes,...
Biovitrum's Project Portfolio Advances -- Pharmaceutical Project for the Treatment of Glaucoma Enters Phase I
13 sept. 2005 04h16 HE
|
Biovitrum
STOCKHOLM, Sweden, Sept. 13, 2005 (PRIMEZONE) -- The glaucoma candidate drug (BVT.28949) has been internally developed within Biovitrum and the first clinical study for safety testing was entered in...
Biovitrum Acquires the Pharmaceutical Company Arexis
22 août 2005 03h15 HE
|
Biovitrum
STOCKHOLM, Sweden, Aug. 22, 2005 (PRIMEZONE) -- Biovitrum expands the project portfolio with projects in clinical phase, both I and II, together with additional preclinical projects within its...
Biovitrum and Santhera Sign an Exclusive License and Collaboration Agreement for the Development of DPP-IV Inhibitors for the Treatment of Type 2 Diabetes and Other Metabolic Diseases
17 août 2005 02h10 HE
|
Biovitrum
STOCKHOLM, Sweden, Aug. 17, 2005 (PRIMEZONE) -- Biovitrum AB, Sweden, and Swiss-based Santhera Pharmaceuticals AG have signed a license and collaboration agreement that grants Biovitrum the exclusive...
Biovitrum Starts Collaboration with Karolinska Institutet in Inflammation Research
31 mai 2005 10h16 HE
|
Biovitrum
STOCKHOLM, Sweden, May 31, 2005 (PRIMEZONE) -- Biovitrum AB and Karolinska Institutet (KI) have signed an agreement implicating that Biovitrum Biopharmaceuticals on behalf of the Department of Woman...
Biovitrum Completes Acquisition of Cambridge Biotechnology Ltd.
25 avr. 2005 08h05 HE
|
Biovitrum
STOCKHOLM, Sweden, April 25, 2005 (PRIMEZONE) -- An extra annual general meeting of the shareholders in Biovitrum AB has taken the formal decisions required to complete the acquisition of Cambridge...
Maria Berggren New Vice President Human Resources at Biovitrum
18 avr. 2005 03h03 HE
|
Biovitrum
STOCKHOLM, Sweden, April 18, 2005 (PRIMEZONE) -- Maria Berggren has been recruited as the new Vice President Human Resources at Biovitrum. Maria will be a member of the senior management team and...
Diamyd Assigns Biovitrum Development of Production Process for its Diabetes Drug GAD65, Currently in Clinical Trials
04 avr. 2005 07h06 HE
|
Biovitrum
STOCKHOLM, Sweden, April 4, 2005 (PRIMEZONE) -- Diamyd Medical AB and Biovitrum AB have signed an agreement covering the market adaptation of the production process for GAD65, Diamyd's product for...
Biovitrum Acquires Cambridge Biotechnology Ltd
21 mars 2005 12h49 HE
|
Biovitrum
STOCKHOLM, Sweden, March 21, 2005 (PRIMEZONE) -- Biovitrum today announces that the company has agreed to acquire Cambridge Biotechnology Ltd ("CBT"), a Cambridge UK based private drug discovery...
Anna Karin Kallen New Vice President Communications For Biovitrum
26 janv. 2005 08h26 HE
|
Biovitrum
STOCKHOLM, Sweden, Jan. 26, 2005 (PRIMEZONE) -- Anna Karin Kallen has been recruited to the position of Vice President of Communications at Biovitrum. Anna Karin will be a member of the senior...